Skip to main content

Advertisement

SpringerLink
Log in

Vestibular Migraine

  • Headache (R.B. Halker Singh and J. VanderPluym, Section Editors)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To explore recent developments in vestibular migraine (VM).

Recent Findings

This review discusses the current diagnostic criteria for VM in the adult and pediatric populations, as proposed by the International Headache Society and Bárány Society. Recent VM studies confirm the prior findings and reveal new insights, including the wide range of vestibular symptoms, symptoms in the attack-free period, and triggers. Many patients experience persistent vestibular symptoms, even in the absence of acute attacks, which often significantly impact patients’ quality of life. The syndrome of benign recurrent vertigo and its relationship to migraine, VM, and Meniere’s disease is also discussed. There is a dearth of randomized controlled trials in VM treatment. Prospective and retrospective studies support the benefit of many migraine treatments are effective in VM, including neuromodulation, and calcitonin gene-related peptide monoclonal antibodies.

Summary

VM affects almost 3% of the population, but remains under-diagnosed. Recent diagnostic criteria can help clinicians diagnose VM in adults and children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Neuhauser HK, Radtke A, von Brevern M, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67:1028–33 (This was the first study to investigate the prevalence of VM).

    Article  CAS  PubMed  Google Scholar 

  2. • Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol. 2018;39:1037–44 (This study looks at the prevalence of VM in the population using the 2012 diagnostic criteria).

    Article  PubMed  Google Scholar 

  3. Geser R, Straumann D. Referral and final diagnoses of patients assessed in an academic vertigo center. Frontiers Neurol. 2012;3:169.

    Article  Google Scholar 

  4. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246:883–92.

    Article  CAS  PubMed  Google Scholar 

  5. •• Lempert T, Olesen J, Furman J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22:167–72 (This manuscript publishes the diagnostic criteria for VM in adults).

    Article  PubMed  Google Scholar 

  6. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

  7. •• Van de Berg R, Widdershoven J, Bisdorff A, et al. Vestibular migraine and recurrent vertigo of childhood: diagnostic criteria consensus document of the Classification Committee of Vestibular Disorders of the Barany Society and the International Headache Society. J Vestib Res. 2021;31:1–9 (The diagnostic criteria of VM in the pediatric population is reviewed).

    Article  PubMed  PubMed Central  Google Scholar 

  8. •• Beh SC. Vestibular migraine: how to sort it out and what to do about it. J Neuroophthalmol. 2019;39:208–19 (This is comprehensive review of VM looks at its clinical features, differential diagnoses, and treatments).

    Article  PubMed  Google Scholar 

  9. • Teggi R, Colombo B, Albera R, et al. Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: the VM-Phenotypes Projects. Headache. 2018;58:534–44 (This large study analyzes the clinical features of VM in a cohort of patients.).

    Article  PubMed  Google Scholar 

  10. • Beh SC, Masrour S, Smith SV, Friedman DI. The spectrum of vestibular migraine: clinical features, triggers, and examination findings. Headache. 2019;59:727–40 (This study investigates the clinical features of VM in a large cohort of patients).

    Article  PubMed  Google Scholar 

  11. Power L, Shute W, McOwan B, Murray K, Szmulewicz D. Clinical characteristics and treatment choice in vestibular migraine. J Clin Neurosci. 2018;52:50–3.

    Article  CAS  PubMed  Google Scholar 

  12. Vuralli D, Yildirim F, Akcali DT, et al. Visual and postural motion-evoked dizziness symptoms are predominant in vestibular migraine. Pain Med. 2018;19:178–83.

    Article  PubMed  Google Scholar 

  13. • Young AS, Nham B, Bradshaw AP, et al. Clinical, oculographic, and vestibular test characteristics of vestibular migraine. Cephalalgia. 2021;41:1039–52 (This study investigates the clinical feature of a cohort of VM patients).

    Article  PubMed  Google Scholar 

  14. • Celebisoy N, Ak AK, Ozdemir HN, et al. Vestibular migraine, demographic and clinical features of 415 patients: a multicenter study. Clin Neurol Neurosurg. 2022;215:107201 (This study analyzes the features of VM in a large cohort of patients).

    Article  PubMed  Google Scholar 

  15. Strupp M, Brandt T, Huppert D, Grill E. Prevalence of motion sickness in various vestibular disorders: a study on 749 patients. J Neurol. 2018;265(Supp 1):95–7.

    Article  PubMed  Google Scholar 

  16. Thakar A, Anjaneyulu C, Deka RC. Vertigo syndromes and mechanisms in migraine. J Laryngol Otol. 2001;115:782–7.

    Article  CAS  PubMed  Google Scholar 

  17. • Paz-Tamayo A, Perez-Carpena P, Lopez-Escemez JA. Systematic review of prevalence studies and familial aggregation in vestibular migraine. Front Genet. 2020;11:954 (This review explores the heritability of VM).

    Article  PubMed  PubMed Central  Google Scholar 

  18. • Dlugaicyzk J, Lempert T, Lopez-Escamez JA, et al. Recurrent vestibular symptoms not otherwise specified: clinical characteristics compared with vestibular migraine and Meniere’s disease. Front Neurol. 2021;12:674092 (This study investigates the clinical features of RVS-NOS, and compares it to VM and MD).

    Article  Google Scholar 

  19. Wattiez AS, O’Shea SA, Eyck PT, et al. Patients with vestibular migraine are more likely to have occipital headaches than those without migraine without vestibular symptoms. Headache. 2020;60:1581–91.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Beh SC, Masrour S, Smith SV, Friedman DI. Clinical characteristics of Alice in Wonderland syndrome in a cohort with vestibular migraine. Neurol Clin Pract. 2018;8:389–96.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chari DA, Liu YH, Chung JJ, Rauch SD. Subjective cognitive symptoms and dizziness handicap inventory (DHI) performance in patients with vestibular migraine and Meniere’s disease. Otol Neurotol. 2021;42:883–9.

    Article  PubMed  Google Scholar 

  22. Benjamin T, Gillard D, Abouzari M, et al. Vestibular and auditory manifestations of migraine. Curr Opin Neurol. 2022;25:84–9.

    Article  Google Scholar 

  23. Belinchon A, Perez-Garrigues H, Tenias JM, et al. Evolution of symptoms in Meniere’s disease. Audiol Neurootol. 2012;17:126–32.

    Article  PubMed  Google Scholar 

  24. Pyykko I, Nakashima T, Yoshida T, Zou J, Naganawa S. Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualization of endolymphatic hydrops. BMJ Open. 2013;3:e001555.

    Article  PubMed  PubMed Central  Google Scholar 

  25. • Espinosa-Sanchez JM, Lopez-Escamez JA. Meniere’s disease. Handb Clin Neurol. 2016;137:257–77 (This is a comprehensive review of Meniere’s disease).

    Article  CAS  PubMed  Google Scholar 

  26. Shin JE, Kim CH, Park HJ. Vestibular abnormality in patients with Meniere’s disease and migrainous vertigo. Acta Otolaryngol. 2013;133:154–8.

    Article  PubMed  Google Scholar 

  27. Radtke A, Lempert T, Gresty MA, et al. Migraine and Meniere’s disease – is there a link? Neurology. 2002;59:1700–4.

    Article  CAS  PubMed  Google Scholar 

  28. Brantberg K, Baloh RW. Similarity of vertigo attacks due to Meniere’s disease and benign recurrent vertigo, both with and without migraine. Acta Otolaryngol. 2011;131:722–7.

    Article  PubMed  Google Scholar 

  29. Lopez-Escamez JA, Carey J, Chung WH, et al. Diagnostic criteria for Meniere’s disease. J Vestib Res. 2015;25:1–7.

    Article  PubMed  Google Scholar 

  30. Gedik-Soyyuce O, Yalinay-Dikmen P, Korkut N. The effect of migraine and motion sickness on symptoms evoked by the caloric vestibular test. J Vestib Res. 2022;32:135–44.

    Article  Google Scholar 

  31. Cha YH, Brodsky J, Ishiyama G, Sabatti C, Baloh RW. The relevance of migraine in patients with Meniere’s disease. Acta Otolaryngol. 2007;127:1241–5.

    Article  CAS  PubMed  Google Scholar 

  32. Shin CH, Kim Y, Yoo MH, et al. Management of Meniere’s disease: how does the coexistence of vestibular migraine affect outcome? Otol Neurotol. 2019;40:666–73.

    Article  PubMed  Google Scholar 

  33. • Yamani N, Chalmer MA, Olesen J. Migraine with brainstem aura: defining the core syndrome. Brain. 2019;142:3868–75 (This study is an up-to-date investigation on migraine with brainstem aura).

    Article  PubMed  Google Scholar 

  34. Winnick A, Sadeghpour S, Otero-Millan J, et al. Errors of upright perception in patients with vestibular migraine. Front Neurol. 2018;9:982.

    Article  Google Scholar 

  35. Li F, Xu J, Li GR, et al. The value of subjective visual vertical in the diagnosis of vestibular migraine. Curr Med Sci. 2021;41:654–60.

    Article  PubMed  Google Scholar 

  36. Baier B, Winkenwerder E, Dieterich M. “Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective study J Neurol. 2009;256:436–42.

    PubMed  Google Scholar 

  37. Zuniga MG, Janky KL, Schubert MC, et al. Can vestibular-evoked myogenic potentials help differentiate M_enie`re disease from vestibular migraine? Otolaryngol Head Neck Surg. 2012;146:788–96.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Boldingh MI, Ljostad U, Mygland A, et al. Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility. Cephalalgia. 2011;31:1211–9.

    Article  PubMed  Google Scholar 

  39. Ozdemir D, Akpinar CK, Kucukoner O, et al. Vestibular evoked myogenic potential (VEMP) results in migraine and migrainous vertigo. Acta Oto-Laryngol. 2020;140:140–3.

    Article  Google Scholar 

  40. Roceanu A, Allena M, de Pasqua V, et al. Abnormalities of the vestibulo-collic reflex are similar in migraineurs with and without vertigo. Cephalalgia. 2008;28:988–90.

    Article  CAS  PubMed  Google Scholar 

  41. Taylor RL, Zagami AS, Gibson WP, et al. Vestibular evoked myogenic potentials to sound and vibration: characteristics in vestibular migraine that enable separation from Meniere’s disease. Cephalalgia. 2012;32:213–25.

    Article  PubMed  Google Scholar 

  42. Zaleski A, Bogle J, Starling A, et al. Vestibular evoked myogenic potentials in patients with vestibular migraine. Otol Neurotol. 2015;36:295–302.

    Article  PubMed  Google Scholar 

  43. Salviz M, Yuce T, Acar H, Taylan I, Yuceant GA, Karatas A. Diagnostic value of vestibular-evoked myogenic potentials in Meniere’s disease and vestibular migraine. J Vestib Res. 2016;25:261–6.

    Article  PubMed  Google Scholar 

  44. Rizk HG, Liu YF, Strange CC, et al. Predictive value of vestibular evoked myogenic potentials in the diagnosis of Meniere’s disease and vestibular migraine. Otol Neurotol. 2020;41:828–35.

    Article  PubMed  Google Scholar 

  45. Makowiec KF, Piker EG, Jacobson GP, Ramadan NM, Roberts RA. Ocular and cervical vestibular evoked myogenic potentials in patients with vestibular migraine. Otol Neurotol. 2018;39:e561–7.

    Article  PubMed  Google Scholar 

  46. Dlugaiczyk J, Habs M, Dieterich M. Vestibular myogenic evoked potentials in vestibular migraine and Meniere’s disease: cVEMPs make the difference. J Neurol. 2020;267:169–80.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psychiatry. 1979;42:363–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Leliever WC, Barber HO. Recurrent vestibulopathy. Laryngoscope. 1981;91:1–6.

    Article  CAS  PubMed  Google Scholar 

  49. • Pan Q, Zhang Y, Zhang S, et al. Clinical features and outcomes of benign recurrent vertigo: a longitudinal study. Acta Neurol Scand. 2020;141:374–9 (This study analyzes the clinical features of BRV in a cohort of patients).

    Article  PubMed  Google Scholar 

  50. • Van Leeuwen RB, Colijn C, van Esch BF, Schermer TR. Benign recurrent vertigo: the course of vertigo attacks compared to patients with Meniere’s disease and vestibular migraine. Front Neurol. 2022;13:817812 (This study investigates the clinical features of BRV in a cohort of patients, and compares it to VM and MD).

    Article  PubMed  PubMed Central  Google Scholar 

  51. King S, Priesol AJ, Davidi SE, et al. Self-motion perception is sensitized in vestibular migraine: pathophysiologic and clinical implications. Sci Rep. 2019;19:14323.

    Article  Google Scholar 

  52. Wurthmann S, Naegel S, Roesner M, et al. Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: a cross-sectional study. Eur J Neurol. 2021;28:2357–66.

    Article  PubMed  Google Scholar 

  53. Abouzari M, Cheung D, Pham T, et al. The relationship between vestibular migraine and motion sickness susceptibility. Otol Neurotol. 2020;41:1116–21.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Wang A, Fleishman KM, Kawai K, et al. Persistent postural-perceptual dizziness in children and adolescents. Otol Neurotol. 2021;42:e1093–100.

    Article  PubMed  Google Scholar 

  55. Waterston J, Chen L, Mahony K, et al. Persistent postural-perceptual dizziness: precipitating conditions, co-morbidities and treatment with cognitive behavioral therapy. Front Neurol. 2021;12:795516.

    Article  PubMed  PubMed Central  Google Scholar 

  56. • Beh SC, Chiang HS, Sanderson C. The interconnections of mal de debarquement syndrome and vestibular migraine. Laryngoscope. 2021;131:E1653–61 (This retrospective study investigates the clinical features, and treatment of patients with VM and mal de debarquement syndrome).

    CAS  PubMed  Google Scholar 

  57. Donaldson LF, Yan F, Liu YF, et al. Does cognitive dysfunction correlate with dizziness severity in patients with vestibular migraine? Am J Otolaryngol. 2021;42:103124.

    Article  PubMed  Google Scholar 

  58. Toupet M, Van Nechel C, Hautefort C, et al. Influence of visual and vestibular hypersensitivity on derealization and depersonalization in chronic dizziness. Front Neurol. 2019;10:69.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Huang RJ, Smith SL, Brezina L, Riska KM. A comparison of falls and dizziness handicap by vestibular diagnosis. Am J Audiol. 2021;30:1048–57.

    Article  PubMed  Google Scholar 

  60. Chae R, Krauter R, Pasquesi JL, Sharon JD. Broadening the vestibular migraine diagnosis criteria: a prospective cohort study on vestibular migraine subtypes. J Vestib Res 2022 [online ahead of print].

  61. Teggi R, Caldirola D, Colombo B, Perna G, Comi G, Bellodi L, et al. Dizziness, migrainous vertigo and psychiatric disorders. J Laryngol Otol. 2010;124:285–90.

    Article  CAS  PubMed  Google Scholar 

  62. Brandt T, Dieterich M. ‘Excess anxiety’ and ‘less anxiety’: both depend on vestibular function. Curr Opin Neurol. 2020;33:136–41.

    Article  PubMed  Google Scholar 

  63. Wu J, Liu C, Yu H, et al. Clinical characteristics of sleep disorders in patients with vestibular migraine. Sleep Breath 2020;24L1383–1388

  64. Xue H, Wang B, Meng T, et al. Differences of sleep disorders between vestibular migraine and benign paroxysmal positional vertigo. Front Psychiatry. 2021;18:726038.

    Article  Google Scholar 

  65. Bigelow RT, Semenov YR, Hoffman HJ, Agrawal Y. Association between vertigo, cognitive, and psychiatric conditions in US children: 2012 National Health Interview Survey. Int Pediatr Otorhinolaryngol. 2020;130:109802.

    Article  Google Scholar 

  66. • Beh SC. External trigeminal nerve stimulation: potential rescue treatment for acute vestibular migraine. J Neurol Sci. 2020;408:116550 (This study details the benefit of ETNS on VM attacks).

    Article  PubMed  Google Scholar 

  67. Beh SC. Nystagmus and vertigo in acute vestibular migraine attacks: response to non-invasive vagus nerve stimulation. Otol Neurotol. 2021;42:e233–6.

    Article  PubMed  Google Scholar 

  68. Teggi R, Gatti O, Familiari M, et al. Skull vibration-induced nystagmus test (SVINT) in vestibular migraine and Meniere’s disease. Audiol Res. 2021;11:603–8.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a placebo-controlled trial. Neurology. 2003;60:882–3.

    Article  CAS  PubMed  Google Scholar 

  70. Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18:350–4.

    CAS  PubMed  Google Scholar 

  71. Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain. 2011;21:81–8.

    Article  Google Scholar 

  72. • Beh SC, Friedman DI. Acute vestibular migraine treatment with noninvasive vagus nerve stimulation. Neurology. 2019;93:e1715–9 (This study investigates the benefit of NVNS in acute VM attacks).

    Article  CAS  PubMed  Google Scholar 

  73. • Beh SC. Emerging evidence for noninvasive vagus nerve stimulation for the treatment of vestibular migraine. Expert Rev Neurother. 2020;20:991–3 (This review explores how non-invasive vagus nerve stimulation ameliorates VM attacks).

    Article  CAS  PubMed  Google Scholar 

  74. Zhang Y, Zhang Y, Tian K, et al. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine. J Headache Pain. 2020;21:72.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Roberts RA, Watford KE, Picou EM, et al. Effects of lifestyle modification on vestibular migraine. Otol Neurotol. 2021;42:e1537-E1543.

    Article  PubMed  Google Scholar 

  76. Lee YY, Yang YP, Huang PI, et al. Exercise suppresses COX-2 pro-inflammatory pathway in vestibular migraine. Brain Res Bull. 2015;116:98–105.

    Article  CAS  PubMed  Google Scholar 

  77. Sun L, Li G, Liu F, et al. Resistance exercise relieves symptoms of vestibular migraine patients with MRI diagnosis: a randomized parallel-controlled single-blind clinical trial. Rev Neurol (Paris). 2021;S0035–3787(21):0062–7.

    Google Scholar 

  78. Stancel-Lewis J, Lau JWL, Male A, et al. Vestibular rehabilitation therapy for the treatment of vestibular migraine, and the impact of traumatic brain injury on outcome: a retrospective study. Otol Neurotol. 2022;43:359–67.

    Article  PubMed  Google Scholar 

  79. •• Bayer O, Adrion C, Al Tawil A, et al. Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG). Trials. 2019;20:813 (This study compared metoprolol to placebo, and although it failed to meet its endpoints, highlights several important points for future clinical trials for VM).

    Article  PubMed  PubMed Central  Google Scholar 

  80. Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo. Eur Arch Otolaryngol. 2014;271:2931–6.

    Article  Google Scholar 

  81. Dominguez-Duran E, Montilla-Ibanez MA, AlvarezMorujo De Sande MG, et al. Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug. Eur Arch Oto-Rhino-Laryngol. 2020;277:1013–21.

    Article  CAS  Google Scholar 

  82. Kaya I, Eraslan S, Tarhan C, et al. Can verapamil be effective in controlling vertigo and headache attacks in vestibular migraine accompanied with Meniere’s disease? A preliminary study J Neurol. 2019;266:S62–4.

    Google Scholar 

  83. Gode S, Celebisoy N, Kirazli T, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50:77–84.

    Article  PubMed  Google Scholar 

  84. Carmona S, Settecase S. Use of topiramate (Topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann NY Acad Sci. 2005;1039:517–20.

    Article  CAS  PubMed  Google Scholar 

  85. Morganti LO, Salmito MC, Duarte HA, et al. Vestibular migraine: clinical and epidemiological aspects. Braz J Otorhinolaryngol. 2016;82:397–402.

    Article  PubMed  Google Scholar 

  86. Liu F, Ma T, Che X, et al. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol. 2017;8:524.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Teggi R, Colombo B, Gatti O, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurological Sci. 2015;36:1869–73.

    Article  CAS  Google Scholar 

  88. Hoskin FL, Fife TD. New anti-CGRP medications in the treatment of vestibular migraine. Front Neurol. 2022;12:799002.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Tian R, Zhang Y, Pan Q, et al. Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus, and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model. J Headache Pain. 2022;23:35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. •• Balaban CD, Black RD, Silberstein SD. Vestibular neuroscience for the headache specialist. Headache. 2019;59:1109–27 (The role of CGRP in the vestibular system is explored in detail in this review).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Beh Center for Vestibular & Migraine Disorders, 4500 Hillcrest Rd Ste 145, Frisco, TX, 75035, USA

    Shin C. Beh

Authors
  1. Shin C. Beh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shin C. Beh.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Headache.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beh, S.C. Vestibular Migraine. Curr Neurol Neurosci Rep 22, 601–609 (2022). https://doi.org/10.1007/s11910-022-01222-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-022-01222-6

Keywords

Search

Navigation